Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Alice, Laffi"'
Autor:
Alexia Francesca Bertuzzi, Maria Susanna Grimaudo, Alice Laffi, Laura Giordano, Nicolò Gennaro, Umberto Cariboni, Licia Vanessa Siracusano, Vittorio Quagliuolo, Piergiuseppe Colombo, D’Orazio Federico, Salvatore Lorenzo Renne, Cristina Specchia, Ferdinando Cananzi, Andrea Marrari, Pierina Navarria, Primo Andrea Daolio, Stefano Bastoni, Armando Santoro
Publikováno v:
Cancer Medicine, Vol 12, Iss 15, Pp 16254-16263 (2023)
Abstract Introduction The aim of this retrospective study was to investigate the clinicopathological characteristics of AYA sarcomas and their clinical outcomes at a high‐volume single center. Methods Demographic, clinicopathological data on the di
Externí odkaz:
https://doaj.org/article/7e41660ffae240f593090873594dd21e
Autor:
Maria Susanna Grimaudo, Alice Laffi, Nicolò Gennaro, Roberta Fazio, Federico D’Orazio, Laura Samà, Licia Vanessa Siracusano, Federico Sicoli, Salvatore Lorenzo Renne, Armando Santoro, Alexia Francesca Bertuzzi
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionRegorafenib is a tyrosine kinase inhibitor (TKI) approved in metastatic gastrointestinal stromal tumor (GIST), colorectal cancer, and hepatocarcinoma. Anyway, the toxicity profile of Regorafenib standard schedule is associated with poor c
Externí odkaz:
https://doaj.org/article/fa4e4a38a65349a0a1ca77fcb062dc2e
Autor:
Alice Laffi, Lorenzo Gervaso, Oriana D’Ecclesiis, Sara Gandini, Agostino Riva, Rita Passerini, Francesca Spada, Stefania Pellicori, Manila Rubino, Chiara Alessandra Cella, Paola Simona Ravenda, Maria Giulia Zampino, Nicola Fazio
Publikováno v:
Biomedicines, Vol 11, Iss 2, p 336 (2023)
The coronavirus disease-19 (COVID-19) pandemic dramatically impacted oncological patients’ care. Since the introduction of vaccines and the demonstration of their benefit on frail patients, COVID-19 vaccinations were indicated to also be beneficial
Externí odkaz:
https://doaj.org/article/8b4124fc0ecd4c1b9c7501dad458b669
Autor:
Alice Laffi, Marzia Colandrea, Giuseppe Buonsanti, Samuele Frassoni, Vincenzo Bagnardi, Francesca Spada, Eleonora Pisa, Massimo Barberis, Manila Rubino, Chiara Maria Grana, Francesco Ceci, Nicola Fazio
Publikováno v:
Diagnostics, Vol 11, Iss 12, p 2401 (2021)
Grade 3 (G3) neuroendocrine tumors (NETs) are a novel category among digestive neuroendocrine neoplasms, characterized by Ki-67 >20% and a well-differentiated morphology, presenting high intra-tumor heterogeneity. We aimed to explore the role of dual
Externí odkaz:
https://doaj.org/article/d5caf8e37bed46f7a54c1e0cb376077d
Autor:
Francesca Spada, Roberta E. Rossi, Elda Kara, Alice Laffi, Sara Massironi, Manila Rubino, Franco Grimaldi, Sherrie Bhoori, Nicola Fazio
Publikováno v:
Pharmaceuticals, Vol 14, Iss 6, p 539 (2021)
The carcinoid syndrome (CS) and hyperinsulinemic hypoglycemia (HH) represent two of the most common clinical syndromes associated with neuroendocrine neoplasms (NENs). The former is mainly related to the serotonin secretion by a small bowel NEN, wher
Externí odkaz:
https://doaj.org/article/17dbd1d9dd1e4497af0fe31f6e1cf0b4
Autor:
Jasminka Hasic Telalovic, Serena Pillozzi, Rachele Fabbri, Alice Laffi, Daniele Lavacchi, Virginia Rossi, Lorenzo Dreoni, Francesca Spada, Nicola Fazio, Amedeo Amedei, Ernesto Iadanza, Lorenzo Antonuzzo
Publikováno v:
Diagnostics, Vol 11, Iss 5, p 804 (2021)
The application of machine learning (ML) techniques could facilitate the identification of predictive biomarkers of somatostatin analog (SSA) efficacy in patients with neuroendocrine tumors (NETs). We collected data from 74 patients with a pancreatic
Externí odkaz:
https://doaj.org/article/5240776656e7484c86abf79abac920e8
Autor:
Chiara A. Cella, Maren Knoedler, Marcia Hall, Michele Arcopinto, Vincenzo Bagnardi, Lorenzo Gervaso, Stefania Pellicori, Francesca Spada, Maria G. Zampino, Paola S. Ravenda, Samuele Frassoni, Antonio Passaro, Monica Milano, Alice Laffi, Nicola Fazio, Florian Lordick
ImportanceThe assessment of the risk of venous thromboembolism (VTE) among outpatients with cancer represents an unsolved topic. Current international guidelines recommend primary prophylaxis for patients at intermediate to high risk of VTE, indicate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::138fc0db73cff81dea5441334f73d334
https://hdl.handle.net/10281/407577
https://hdl.handle.net/10281/407577
Autor:
Alice, Laffi, Andrea Gerardo Antonio Lania, Alberto, Ragni, DI VITO, Valentina, Alessia, Liccardi, Manila, Rubino, Sesti, Franz, Annamaria, Colao, Faggiano, Antongiulio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3686::2cdd3d01c021339231c7bfc1c92c7152
https://hdl.handle.net/11573/1678348
https://hdl.handle.net/11573/1678348
Ten years-experience of sunitinib in the treatment of advanced pan-NETs: an update on safety profile
Publikováno v:
Expert Opinion on Drug Safety. 21:303-310
Introduction Sunitinib still represents a milestone in the treatment for progressive, well-differentiated, advanced panNETs. Areas covered We performed an evidence reappraisal to critically discuss its safety profile. We included nine studies, five c
Autor:
Mohamad Bassam Sonbol, Simona Grozinsky-Glasberg, Anna La Salvia, Manila Rubino, Rocio Garcia-Carbonero, Anna Koumarianou, Maura Rossi, D. Tamayo, Alice Laffi, S. Boselli, Francesca Spada, Gregory Kaltsas, J. Hernando, Wouter W. de Herder, Vincenzo Bagnardi, Nicola Fazio, Johannes Hofland, Jaume Capdevila, Kira Oleinikov, Lorenzo Gervaso, Thorvardur R. Halfdanarson
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 154, 246-252. Elsevier Ltd.
European Journal of Cancer, 154, 246-252. Elsevier Ltd.
Background Specific data regarding coronavirus disease 2019 (COVID-19) in patients with neuroendocrine neoplasms (NENs) are lacking. The aim of this study is to describe the characteristics of patients with NENs who tested severe acute respiratory sy